XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Share-Based Compensation | 9 Months Ended
--- | ---
Dec. 01, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Share-Based Compensation | Share-Based Compensation Total share-based compensation expense included in the results of operations was $4.7 million for the nine-month period ended December 1, 2018 and $4.6 million for the nine-month period ended December 2, 2017. Stock options and SARs Stock option and SAR activity for the current nine-month period is summarized as follows:
Stock options and SARs |  | Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Life |  | Aggregate Intrinsic Value
Outstanding at March 3, 2018 |  | 129,901 |  |  | $ | 11.10 |  |  |  |  |
Awards exercised |  | (29,560 | ) |  | 20.43 |  |  |  |  |
Outstanding and exercisable at December 1, 2018 |  | 100,341 |  |  | 8.34 |  |  | 2.8 years |  | $ | 2,820,586 |
Cash proceeds from the exercise of stock options were $0.2 million and $0.8 million for the nine months ended December 1, 2018 and December 2, 2017, respectively. The aggregate intrinsic value of securities exercised (the amount by which the stock price on the date of exercise exceeded the stock price of the award on the date of grant) was $0.6 million during the nine months ended December 1, 2018 and $4.8 million during the prior-year period. Nonvested shares and share units Nonvested share activity for the current nine-month period is summarized as follows:
Nonvested shares and units |  | Number of Shares and Units |  | Weighted Average Grant Date Fair Value
Nonvested at March 3, 2018 |  | 266,180 |  |  | $ | 49.22 |
Granted |  | 152,487 |  |  | 43.50 |
Vested |  | (116,266 | ) |  | 46.57 |
Canceled |  | (17,942 | ) |  | 48.65 |
Nonvested at December 1, 2018 |  | 284,459 |  |  | 47.24 |
At December 1, 2018, there was $7.9 million of total unrecognized compensation cost related to nonvested share and nonvested share unit awards, which is expected to be recognized over a weighted average period of approximately 20 months. The total fair value of shares vested during the nine months ended December 1, 2018 was $4.9 million.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration